Determination of minimal residual disease in leukaemia patients
Open Access
- 3 June 2003
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 121 (6) , 823-838
- https://doi.org/10.1046/j.1365-2141.2003.04393.x
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemiaBlood, 2003
- Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemiaBlood, 2002
- Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemiaThe Lancet, 2001
- Acute Myeloid LeukemiaNew England Journal of Medicine, 1999
- Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALLLeukemia, 1999
- Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemiaLeukemia, 1999
- Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhoodThe Lancet, 1998
- Minimal residula disease status as a predictor of relapse after allogenic bone marrow transplantation for children with acute lymphoblastic leukaemiaBritish Journal of Haematology, 1998
- Monitoring minimal residual disease in peripheral blood in B‐lineage acute lymphoblastic leukaemiaBritish Journal of Haematology, 1997
- Detection of Residual Acute Lymphoblastic Leukemia Cells in Cultures of Bone Marrow Obtained during RemissionNew England Journal of Medicine, 1986